financetom
Business
financetom
/
Business
/
Fractyl Health Obtains 2 US Patents for Duodenal Resurfacing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fractyl Health Obtains 2 US Patents for Duodenal Resurfacing
Jun 18, 2025 6:14 AM

08:59 AM EDT, 06/18/2025 (MT Newswires) -- Fractyl Health ( GUTS ) said Wednesday that the US Patent and Trademark Office has granted two new patents related to duodenal resurfacing applications.

The two patents are directed to ablating duodenal mucosa with electrical energy, including thermal and non-thermal, the company said.

Fractyl said its intellectual property portfolio now includes 31 granted US patents and around 40 pending US applications, along with foreign-issued patents and pending applications.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mobile Global Esports Shares Fall After Chairman's Resignation
Mobile Global Esports Shares Fall After Chairman's Resignation
Apr 5, 2024
12:54 PM EDT, 04/05/2024 (MT Newswires) -- Mobile Global Esports ( MGAM ) shares slid 7.8% in recent trading after the company said Friday that Chairman Marco Welch resigned on Thursday for personal reasons. Welch will continue to serve the company as a consultant, according to a regulatory filing. Price: 0.13, Change: -0.01, Percent Change: -7.74 ...
Eaton's Multi-Year Catalysts to Power Stock Through Electrical Supercycle, RBC Says
Eaton's Multi-Year Catalysts to Power Stock Through Electrical Supercycle, RBC Says
Apr 5, 2024
12:46 PM EDT, 04/05/2024 (MT Newswires) -- Eaton (ETN) has multi-year catalysts across datacenters, electric vehicles and other aspects of the energy transition that should help propel the stock in the coming years, RBC Capital Markets said in a note emailed Friday. The brokerage upgraded the stock to outperform from sector perform and hiked its price target to $371 from...
S&P Revises Outlook on Precision Drilling to Positive From Stable on Ongoing Debt Reduction
S&P Revises Outlook on Precision Drilling to Positive From Stable on Ongoing Debt Reduction
Apr 5, 2024
12:55 PM EDT, 04/05/2024 (MT Newswires) -- S&P Global Ratings on Friday revised its outlook on Precision Drilling ( PDS ) to positive from stable and affirmed the B+ issuer credit rating. Also, the rating agency affirmed the B+ issue-level rating on the company's senior unsecured notes while revising the recovery rating to 3 from 4. The positive outlook reflects...
Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity
Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity
Apr 5, 2024
Friday, Protara Therapeutics Inc ( TARA ) shared data from three-month evaluable carcinoma in situ (CIS) patients treated across TARA-002 program, the company’s investigational cell-based therapy, in high-risk Non-Muscle Invasive Bladder Cancer (NMIBC), including Bacillus Calmette-Guérin (BCG)-Unresponsive, BCG-Experienced and BCG-Naïve patient populations. Data were derived from three-month evaluable NMIBC patients with CIS pooled across the company’s ADVANCED-1 Phase 1a, Phase 1b-expansion and ADVANCED-2...
Copyright 2023-2026 - www.financetom.com All Rights Reserved